Rheumatoid arthritis

PM 10 increases mortality risk in rheumatoid arthritis-associated interstitial lung disease

RMD OpenPublished Cohort study

Main finding · Mortality, high vs low PM10 exposureResult — go to the resultHazard ratio 1.68 95% CI 1.11–2.52

Authors' conclusion

Our results indicated that high PM10 exposure may be associated with mortality in patients with RA-ILD.

Study context

Population
Patients with RA-ILD (mean age 61.7 years; male 44.3%)median follow-up 4.8 years
Participants
309 patients
Exposure
High vs low long-term exposure to PM10 and NO2
Outcome
Mortality (death or lung transplantation)
Methodological detailsCox proportional hazards model adjusted for individual-level and area-level characteristics, national-scale exposure prediction model
  • Cox proportional hazards model adjusted for individual-level and area-level characteristics
  • National-scale exposure prediction model

Main finding

Mortality, high vs low PM10 exposure

Hazard ratio

1.68

95% CI 1.11–2.52

P = 0.013

High exposurevs Low exposure
HR 1.68 (95% CI 1.11–2.52); P = 0.013

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Mortality, highvs low PM10 exposure, patients aged <65 years (subgroup)1.98 (1.02–3.85)P = 0.045

Death or lung transplantation

Patients who died or underwent lung transplantation
40.8%
Annual average PM10 concentration
56.3 μg/m³
Annual average NO2 concentration
22.4 ppb

Original publication

PM 10 increases mortality risk in rheumatoid arthritis-associated interstitial lung disease. RMD Open. Published 8 February 2024. doi:10.1136/rmdopen-2023-003680

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.